Received Jun 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 2 | 945663 | IM / LA |
Patient received 2nd dose only 2 weeks after first dose. @nd dose invalid due to be given too soon. Patient only stated they felt tired no other reaction noted.
none
HIV, HTN, Anxiety
unknown
no